RatnerPrestia Elects Andrew Koopman as Shareholder

Philadelphia, PA | June 2018 – RatnerPrestia is pleased to announce that Andrew J. Koopman has become a Shareholder of the firm, effective June 1, 2018. Andy joined RP in 2008 and has most recently held the position of Associate.  He specializes in both patent litigation while also handling an active high-end prosecution docket.  He […]

Read more

Failure to Consider U.S. Export Control Regulations Can be Costly

Written by: Brett J. Rosen Export controls are laws and regulations that regulate and restrict the release of sensitive technologies and information to foreign countries and foreigners, both within and outside of the United States, for reasons of national security and foreign policy.  U.S. export control laws are often overlooked by companies of all sizes […]

Read more

USPTO Proposes Rulemaking to Require the PTAB to Construe Claims According to Phillips in AIA Trials

Written by: Christopher H. Blaszkowski & Alyssa R.M. Pugh The USPTO has issued a notice of proposed rulemaking concerning its intention to replace the current “broadest reasonable interpretation” (BRI) claim construction standard in AIA trials with the “ordinary and customary meaning” standard set forth in Phillips v. AWH Corp., 415 F.3d 1303, 1313 (Fed. Cir. […]

Read more

The PTAB’s New “Binary Decision” to Institute in AIA Trials—All Claims and All Grounds of Invalidity, or None at All

Written by: Christopher H. Blaszkowski Just a few weeks ago, the U.S. Supreme Court issued SAS Institute Inc. v. Iancu, holding that that the Patent Trial and Appeal Board (PTAB) must issue a final written decision as to any patent claim challenged by an IPR petitioner. Two days later, the PTAB issued written guidance explaining that it will, […]

Read more

German Federal Patent Court Rules That Royalties Under a Compulsory License Must Be Paid Until Patent Revocation

Written by: Fritz Wetzel, Ph.D. Last year, the German Federal Patent Court concluded that Merck is entitled to a compulsory license from Shinogi to continue the sale of its HIV medicine Isentress®. The written reasoning for that decision is now available. This is the first time that the Federal Patent Court granted a compulsory license […]

Read more

RatnerPrestia’s Munich Office Joins the CLIB2021 Cluster

Munich, Germany | May 2018 – RatnerPrestia’s Munich office was recently accepted into CLIB2021.  CLIB2021 seeks members that are competent in all fields of biotechnology as well as members that are skilled in IP and legal issues and techno-economic evaluation.  It strives to include members with market entry and access to industrial sites (for SMEs).  RatnerPrestia […]

Read more

Benjamin E. Leace Receives PBI’s 9th Annual Arthur Seidel Distinguished IP Services Award

Philadelphia, PA | April 2018 – RatnerPrestia is pleased to announce that Benjamin E. Leace is the recipient of the 9th annual Arthur Seidel Distinguished IP Services Award.  This honor presented by the Pennsylvania Bar Institute recognizes Mr. Leace’s commitment to the highest standard of excellence in Intellectual Property Law.  The award was established in memory of […]

Read more

Benjamin E. Leace & Christopher H. Blaszkowski Present at PBI’s 2018 Intellectual Property Law Institute

Philadelphia, PA | April 2018 – Benjamin Leace and Christopher Blaszkowski will present at the 2018 Intellectual Property Law Institute two day program hosted by the Pennsylvania Bar Association.  Their presentation, “Amendment after Aqua Products:  Where Did the Burden Go?”, will focus on PTAB trends after Aqua Products and strategies to address this change in the law.  The program […]

Read more

Inter Partes Review Is Here To Stay – Supreme Court Upholds Constitutionality

Written by: Christopher H. Blaszkowski & Alyssa R.M. Pugh In a 7-2 decision, Justice Thomas delivered an opinion in Oil States Energy Services, LLC v. Greene’s Energy Group, LLC holding that the inter partes review process is constitutional under both Article III and the Seventh Amendment. The determinative issue before the Court was whether patent […]

Read more

Jonathan H. Spadt to Present a Keynote at the 92nd ACS Colloid and Surface Science Symposium

Philadelphia, PA | April 2018 – This June, RP’s CEO & President Jonathan H. Spadt, will give a keynote address at the 92nd American Chemical Society’s Colloid and Surface Science Symposium. The event will take place June 10 to 13, 2018, at The Penn Stater Hotel and Conference Center, located in State College, Pennsylvania.  The Symposium continues […]

Read more

Previous Entries